Cencora earnings were $1.7B for the trailing 12 months ending Mar 31, 2025, with -5.8% growth year over year. The latest COR earnings report on Mar 31, 2025 announced Q1 2025 earnings of $717.9M, up 46.9% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, COR reported annual earnings of $1.5B, with -13.5% growth.
COR past earnings growth
How has COR's earnings growth performed historically?
On COR's earnings call on Invalid Date, Cencora (NYSE: COR) reported Q1 2025 earnings per share (EPS) of $3.70, up 75.36% year over year. Total COR earnings for the quarter were $717.87 million. In the same quarter last year, Cencora's earnings per share (EPS) was $2.11.
As of the last Cencora earnings report, Cencora is currently profitable. Cencora's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $1.69 billion, a 8.59% decrease year over year.
What was COR's earnings growth in the past year?
As of Cencora's earnings date in Invalid Date, Cencora's earnings has grown -5.84% year over year. This is 40.6 percentage points lower than the US Medical Distribution industry earnings growth rate of 34.76%. COR earnings in the past year totalled $1.69 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.